SCHEMBL4037569

SCHEMBL4037569

Cn1ncc(Cl)c1-c1cc(NC(=O)CNc2ccc(Cl)cc2)ccc1OCCN1CCOCC1

nearest known ligand 0.82

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 20/20 0.82
HTR2C P28335 20/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4034940 0.94 HTR2A (0.76) HTR2AHTR2C
SCHEMBL4538316 0.93 HTR2A (0.71) HTR2AHTR2C
SCHEMBL1166098 0.90 HTR2A (0.82) HTR2AHTR2C
SCHEMBL1165385 0.90 HTR2A (1.00) HTR2AHTR2C
SCHEMBL3947503 0.90 HTR2A (0.81) HTR2AHTR2C
SCHEMBL3948057 0.89 HTR2A (0.80) HTR2AHTR2C
SCHEMBL1165672 0.89 HTR2A (0.79) HTR2AHTR2C
SCHEMBL3953966 0.89 HTR2A (0.74) HTR2AHTR2C
SCHEMBL3950293 0.89 HTR2A (0.67) HTR2AHTR2C
SCHEMBL1165378 0.89 HTR2A (0.84) HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2051978-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2009-04-29 EP claimed
WO-2007136875-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-11-29 WO claimed
EP-2051978-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2009-04-29 EP disclosed
EP-1562589-B1 DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMA (US) 2009-01-07 EP disclosed
WO-2007136875-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-11-29 WO disclosed